OMCL (omnicell.com) Business Value to Revenue

Public company logo of Omnicell Inc (OMCL)

The EV/Sales trend on the GURU.Markets chart illustrates Omnicell, Inc. (OMCL) dependence on clinic capital expenditures for medication dispensing security, where the 1116.81 mark serves as a key metric. The business possesses high macro-resilience and low demand cyclicality. Stringent FDA and DEA regulations create a powerful ecosystem with colossal software switching costs, guaranteeing total customer retention.

OMCL omnicell.com: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for Omnicell Health (OMCL)

- share price and expert price forecast:
- business market valuation indicators:
Initial company analysis:OMCL, omnicell.com
Manufactured product of Omnicell Corp

Investors are assessing the potential of Omnicell, Inc. (OMCL) through the lens of how effectively it monetizes its technological assets. This metric compares the total enterprise value, including debt minus cash, against annual sales to determine the actual market price of one dollar of revenue. Analyzing the enterprise value-to-revenue ratio allows for the removal of the impact of the debt load. The stability of this indicator confirms the value of retained IT personnel and robotics experts, which ensures capitalization remains resilient while scaling the cloud architecture.

Competitor analysis

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|Total Company Value-to-Revenue Ratio GoodRx Inc (GDRX)|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)